By Elizabeth Lopatto, a reporter who writes about tech, money, and human behavior. She joined The Verge in 2014 as science editor. Previously, she was a reporter at Bloomberg. Hims…
A risk score biomarker that identifies a “hungry gut” phenotype might help determine whether semaglutide medications such as Wegovy are more likely to help a person lose weight, according to…
Recently, GLP-1 drugs like Ozempic and Wegovy have become extremely popular for weight loss. A recent survey finds that 1 in8 people in the United States have taken one of…
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections CNBCsource